Nine samples of human lymphocytes from six healthy subjects were treated in vitro for 24 hours with [3H]-benzo[a]pyrene (BaP) and unlabelled (-)-BaP-7,8-dihydrodiol; 1μg/ml and 0.5μg/ml, respectively. The separation by HPLC of BaP-DNA adducts showed a significant formation of syn-BaPDE-dGuo adducts in five out of the nine human lymphocyte samples treated in vitro with [3H]-BaP. BaP-(7,10/8,9) tetrol and BaP-(7/8,9,10) tetrol derived from (+)-anti-BaPDE were the predominant isomers extracted from the culture medium of all the lymphocyte samples treated with (-)-BaP-7,8-dihydrodiol (mean ratio of anti-BaPDE/syn-BaPDE tetrols 5.6 + 1.2), suggesting that the metabolic activation of (-)-BaP-7,8-dihydrodiol occurred by its epoxidation to (+)-anti-BaPDE much more frequently (4–8 times) than by epoxidation to the (-)-syn-BaPDE form. In contrast to the predominant formation of anti-BaPDE tetrols, the analysis by HPLC of DNA adducts in the five subjects examined also revealed the significant formation of syn-BaPDE-DNA adducts (mean adduct ratio of (+)-anti-/(-)-syn-BaPDE-DNA = 2.6 ± 0.7). In six human lymphocyte samples treated in vitro with anti-BaPDE and syn-BaPDE, the anti-BaPDE bound to DNA 2–5 times more efficiently than did the syn-BaPDE. However, after 24 hours, the level of anti-BaPDE-DNA adducts significantly decreased almost to the level of the syn-BaPDE-DNA adducts, suggesting that a stereoselective repair mechanism could have preferentially removed the anti-BaPDE-DNA adducts.
GelboinH.V. (1980). Benzo[a]pyrene metabolism activation and carcinogenesis: role and regulation of mixed function oxidases and related enzymesPhysiological Review60, 1107–1166
2.
ConneyA.H. (1982). Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons.Cancer Research42, 4875–4917.
3.
HubermanE., SachsL., YangS.K., & GelboinH.V. (1976). Identification of mutagenic metabolites of benzo[a]pyrene in mammalian cells.Proceedings of the National Academy of Sciences of the United States of America73, 607–611.
4.
StowersS.J., and AndersonM.W. (1985). Formation and persistence of benzo[a]pyrene metabolite-DNA adducts.Environmental Health Perspectives61, 31–39.
5.
SingerB., and GrunbergerD. (1983). Molecular Biology of Mutagens and Carcinogens. pp. 97–141. New York: Plenum Press.
6.
SebtiS.M., Pruess-SchwartzD., & BairdW.M (1985). Species and length of time of exposure-dependent differences in the benzo[a]pyrene: DNA adducts formed in embryo cell cultures from mice, rats and hamsters.Cancer Research45, 1594–1600.
7.
KurokiT., HosomiJ., MunakataK., OnizukaT., TerauchiM., and NemotoN. (1982). Metabolism of benzo[a]pyrene in epidermal keratinocytes and dermal fibroblasts of humans and mice with reference to variation among species, individuals and cell types.Cancer Research42, 1859–1865.
8.
SlagaT.J., BrackenW.J., GleasonG., LevinW., YagiH., JerinaD.M., and ConneyA.H. (1979). Marked differences in the skin tumor-initiating activities of the optical enantiomers of the diaster-eomeric benzo[a]pyrene 7,8-diol-9,10-epoxides.Cancer Research39, 67–71.
9.
AlexandrovK., SalaM., and RojasM. (1988). Differences in the DNA adducts formed in cultured rabbit and rat dermal fibroblasts by benzo[a]-pyrene and (-)benzo[a]pyrene-7,8-diol.Cancer Research48, 7132–7139.
10.
KapitulnikJ., WislockiP.G., LevinW., YagiH., JerinaD.M., and ConneyA.H. (1978). Tumorigenicity studies with diol-epoxides of benzo[a]pyrene which indicate that (±)-trans-7β,8-dihydroxy-9,10-epoxy-7,8,9,10- tetrahydrobenzo[a]pyrene is an ultimate carcinogen in newborn mice.Cancer Research38, 354–358.
11.
WoganG.N. (1989). Markers of exposure to carcinogens.Environmental Health Perspectives81, 9–17.
12.
PaleologoM., Van SchootenF.J., PavanelloS., KriekE., ZordanM., ClonferoE., BezzeG., and LevisA.G. (1992). Detection of benzo[a]pyrene-diol-epoxide-DNA adducts in white blood cells of psoriatic patients treated with coal tar.Mutation Research, 281, 11–16.
13.
GuptaR.C., EarlyK., and SharmaS. (1988). Use of human blood lymphocytes to measure DNA binding of chemical carcinogens.Proceedings of the National Academy of Sciences of the United States of America85, 3513–3517.
14.
NowakD., Schmidt-PreussU., JörresR., LiebkeF., and RudigerH.W. (1988). Formation of DNA adducts and water-soluble metabolites of benzo[a]-pyrene in human monocytes is genetically controlled.International Journal of Cancer41, 169–173.
15.
RudigerH.G., NowakD., HetmanK., and CerrutiP. (1985). Enhanced formation of benzo[a]pyrene DNA adducts in monocytes of patients with a presumed predisposition to lung cancer.Cancer Research45, 5890–5894.
16.
ThompsonC.L., McCoyZ., LambertJ.M., AndriesM.J., and LucierG.W. (1989). Relationships among benzo[a]pyrene metabolism, benzo[a]-pyrene-diol-epoxide-DNA adduct formation, and sister-chromatid exchanges in human lymphocytes from smokers and non-smokers.Cancer Research49, 6503–6511.
17.
WienckeJ.K., McDowellM.L., and BodellW.J. (1990). Molecular dosimetry of DNA adducts and sister-chromatid exchanges in human lymphocytes treated with benzo[a]pyrene.Carcinogenesis11, 1497–1502.
18.
JahnkeG.D., ThompsonC.L., WalkerM.P., GallagherJ.E., LucierG.W., and DiaugustineR.P. (1990). Multiple DNA adducts in lymphocytes of smokers and non-smokera determined by 32P-postlabelling analysis.Carcinogenesis11, 205–211.
19.
PavanelloS., RojasM., PaleologoM., LevisA.G., and AlexandrovK. (1989). Evidence for substantial formation of r-7,t-8-dihydroxy-c-9,10-oxy-7,8,9, 10-tetrahydrobenzo[a]pyrene- deoxyguanosine in human lymphocytes treated in vitro with benzo[a]pyrene.Carcinogenesis10, 945–947.
20.
BöyumA. (1976). Isolation of lymphocytes, granulocytes and macrophages.Scandinavian Journal of Immunology, Suppl. 5, 9–15.
21.
PavanelloS., ZanesiN., and LevisA.G. (1992). Detection of (-)-BaP-7,8-dihydrodiol-7,8-dihydro-benzo[a]pyrene metabolites and DNA adducts in cultured human lymphocytes.International Journal of Occupational Medicine and Toxicology1, 1–12.
22.
JohnsM.B., & Paulus-ThomasJ.E. (1989). Purification of human genomic DNA from whole blood using sodium perchlorate in place of phenol.Analytical Biochemistry180, 276–278.
23.
RojasM., and AlexandrovK. (1986). In vivo formation and persistence of DNA adducts in mouse and rat skin exposed to (±)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene and (±)-7, 8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo-[alpyrene.Carcinogenesis7, 1553–1560.
24.
YangS.K., McCourtD.W., RollerP.P., and GelboinH.V. (1976). Enzymatic conversion of benzo[a]-pyrene leading predominantly to the diol-epoxide r-7,t-8-dihydroxy-t-9,10-oxy-7,8,9,10-tetrahydro-benzo[a]pyrene through a single enantiomer of r-7,t-8-dihydroxy-7,8-dihydrobenzo[a]pyrene.Proceedings of the National Academy of Sciences of the United States of America73, 2594–2598.
25.
ThakkerD.R., YagiH., LuA.Y.H., LevinW., ConneyA.H., and JerinaD.M. (1976). Metabolism of benzo[a]pyrene: conversion of (±)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to highly mutagenic 7,8-diol-9,10-epoxides.Proceedings of the National Academy of Sciences of the United States of America73, 3381–3385.
26.
GeacintovN.E., GaglianoA.G., IbanezV., and HarveyR.G. (1982). Spectroscopic characterization and comparison of the structures of the covalent adducts derived from the reactions of 7,8-dihydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene-9-10roxide, and the 9,10-epoxides of 7,8,9,10-tetra-hydrobenzo[a]pyrene, and 9,10,11,12-tetrahydro-benzo[e]pyrene with DNA.Carcinogenesis3, 247–253.
27.
KimM.H., GeacintovN.E., McQuillenD.G., PopeM., and HarveyR.G. (1986). Reaction mechanism of trans-9,10-dihydroxy-anti-7,8-epoxy-7,8,9,10-tetrahydro-3-methylcholanthrene with DNA in aqueous solutions. Conformation of adducts.Carcinogenesis7, 41–77.
28.
UndemanO., LyckesellP.O., GraslundA., AstlindT., EhrembergA., JernstromB., TjerneldF., & NordénB. (1983). Covalent complexes of DNA and two stereoisomers of benzo[a]-pyrene-7,8-dihydrodiol-9,10-epoxide studied by fluorescence and linear dichroism.Cancer Research43, 1851–1860.
29.
SinghS.B., HingertyB.E., SinghU.C., GreenbergJ.P., GeacintovN.E., and BroydeS. (1990). Structures of the (+)- and (-)-(trans-7,8-di-hydroxi-anti-9,10-epoxy-7,8,9,10- tetrahydro-benzo[a]pyrene adducts to guanine-N2 in a duplex dodecamer.Cancer Research81, 3482–3492.
30.
RobertsonI.G.C., JenssonH., MannervikB., & JernströmB. (1986). Glutathione transferases in rat lung: the presence of transferase 7–7, highly efficient in the conjugation of glutathione with the carcinogenic 7β,8α-7,8,9,10- tetrahydrobenzo[a]-pyrene.Carcinogenesis7, 295–299.
31.
RobertsonI.G.C., GuthenbergG., MannervikB., and JernstromB. (1986). Differences in stereo-selectivity and catalytic efficiency of three human glutathione transferases in the conjugation of glutathione with 7β,8α-dihydroxy-9,10-oxy 7,8,9, 10-tetrahydrobenzo[a]pyrene.Cancer Research46, 2220–2224.
32.
HoD., and FahlW.E. (1984). Modification of glutathione levels in C3H/10T1/2 cells and its relationship to benzo[a]pyrene anti-7,8-dihydrodiol 9,10-epoxide-induced cytotoxicity.Journal of Biological Chemistry259, 11231–11235.
33.
JernströmB, DockL., HallM., MannervikB., TahirM.K., and GroverPL. (1989). Glutathione transferase catalyzed conjugation of benzo[a]-pyrene 7,8-diol 9,10-epoxide with glutathione in human skin.Chemico-Biological Interactions70, 173–180.
